Phase II Clinical Study for Anlotinib Combined with Radioactive 125I Seed Implantation in Three-line Treatment of Recurrent or Metastatic Advanced Non-Small Cell Lung Cancer
Latest Information Update: 05 Jul 2019
At a glance
- Drugs Catequentinib (Primary) ; Iodine-125 (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 05 Jul 2019 New trial record